| Date Initiated by Firm | December 03, 2003 |
| Date Posted | January 06, 2004 |
| Recall Status1 |
Terminated 3 on April 20, 2005 |
| Recall Number | Z-0296-04 |
| Recall Event ID |
27874 |
| 510(K)Number | K001009 |
| Product Classification |
C-Reactive Protein, Antigen, Antiserum, And Control - Product Code DCK
|
| Product | POLYMEDCO ULTRA-CRP LATEX ENHANCED ASSAY, Catalog No. CPU400. Contents: 1 x 50 ML R1, 2 x 6 ML R2. R1 is the HIGH SENSITIVE CRP Buffer IVD (50 ml). R2 is the HIGH SENSITIVE CRP Latex IVD (6 ml). For In Vitro Diagnostic (IVD) use only.
COMMON/USUAL NAME: High-Sensitive C-Reactive Protein --- CLASSIFICATION NAME: C-reactive Protein, Antigen, Antiserum |
| Code Information |
Lot numbers 1155J (EXP. 09/04) and 1388J (EXP. 10/04) |
| FEI Number |
1000119795
|
Recalling Firm/ Manufacturer |
Polymedco, Inc 510 Furnace Dock Road Cortlandt Manor NY 10567-6220
|
| For Additional Information Contact | Ms. Helen Landicho 914-739-5400 |
Manufacturer Reason for Recall | Firm was notified by the foreign manufacturer that certain lots of Ultra-CRP are prone to prozone (a condition of antibody antigen excess) and do not meet the labeled specifications. |
FDA Determined Cause 2 | Other |
| Action | By phone on 12/3/03 and by mail on 12/5/03. |
| Quantity in Commerce | 584 Kits |
| Distribution | Medical facilities, physicians, diagnostic laboratories, and distributors located nationwide. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = DCK
|